Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule
15 Mars 2018 - 2:00PM
Amedica Corporation (Nasdaq:AMDA), an innovative biomaterial
company which develops and manufactures silicon nitride as a
platform for biomedical applications, announced today that it
received notification from the Listing Qualifications department of
The NASDAQ Stock Market, that the staff has determined to grant the
Company an extension until June 29, 2018 to regain compliance with
Listing Rule 5620(a) by holding an annual meeting of shareholders
on or before that date. If Amedica does not satisfy
these terms, NASDAQ will provide written notification to the
Company that its common stock will be delisted. At that time, the
Company may appeal the determination to a NASDAQ hearings
panel. The company fully intends to hold an annual meeting of
shareholders by the due date, and otherwise remain in compliance
with NASDAQ rules and regulations.
About Amedica
CorporationAmedica is focused on the development and
application of medical-grade silicon nitride ceramics. Amedica
markets spinal fusion products and is developing a new generation
of wear- and corrosion-resistant implant components for hip and
knee arthroplasty. The Company manufactures its products in its ISO
13485 certified manufacturing facility. Amedica's spine products
are FDA-cleared, CE-marked, and are currently marketed in the U.S.
and select markets in Europe and South America through its
distributor network and its OEM partnerships.
For more information on Amedica
or its silicon nitride material platform, please
visit www.amedica.com.
Forward-Looking Statements
This press release contains statements that
constitute forward-looking statements within the meaning of the
Securities Act of 1933 and the Securities Exchange Act of 1934, as
amended by the Private Securities Litigation Reform Act of 1995.
These statements are based upon our current expectations and speak
only as of the date hereof. Our actual results may differ
materially and adversely from those expressed in any
forward-looking statements as a result of various factors and
uncertainties. For example, there can be no assurance that we will
be able to maintain our listing on any NASDAQ market. Other
factors that could cause actual results to differ materially from
those contemplated within this press release can also be found in
Amedica's Risk Factors disclosure in its Annual Report on Form
10-K/A, filed with the Securities and Exchange Commission (SEC) on
December 27, 2017, and in Amedica's other filings with the
SEC. Forward-looking statements contained in this press
release speak only as of the date of this press release. We
undertake no obligation to update any forward-looking statements as
a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:
Amedica IR
801-839-3502
IR@amedica.com
AMEDICA CORP (NASDAQ:AMDA)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
AMEDICA CORP (NASDAQ:AMDA)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Sintx Technologies (delisted) (NASDAQ): 0 recent articles
Plus d'articles sur